Search for Clinical Trial Results

Sponsored By

Ovarian Hyperstimulation Syndrome - 25 Studies Found

Status Study
Not yet recruiting Study Name: Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
Condition: Ovarian Hyperstimulation Syndrome
Date: 2016-07-14
Interventions:
  • Drug: bromocriptine Patients i
Completed Study Name: Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
Condition: Ovarian Hyperstimulation Syndrome
Date: 2009-11-13
Interventions:
  • Drug: Methylprednisolone Admin
Completed Study Name: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
Condition: Ovarian Hyperstimulation Syndrome
Date: 2009-03-21
Interventions: Drug: Cetrotide acetate cetrotide acetate is a GnRH antagonist. The dose is 3 mg once on the day of oocy
Withdrawn Study Name: The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
Condition: Ovarian Hyperstimulation Syndrome
Date: 2008-02-05
Interventions:
  • Drug: Human Albumin Infusion G
Withdrawn Study Name: Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
Condition: Ovarian Hyperstimulation Syndrome
Date: 2015-03-13
Interventions:
  • Drug: cetrorelix (cetrotide) 0
Active, not recruiting Study Name: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers
Condition: Ovarian Hyperstimulation Syndrome
Date: 2012-02-15
Interventions:
  • Drug: Cabergoline Cabergoline

Completed Study Name: Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome
Condition: Ovarian Hyperstimulation Syndrome
Date: 2008-04-18
Interventions: Drug: Quinagolide • Quinagolide 200 μg/day (dos
Completed Study Name: Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
Condition: Ovarian Hyperstimulation Syndrome (OHSS)
Date: 2012-10-03
Interventions: Other: Highly purified menotropin (HP- hMG) treatment No intervention: patients treated by highly purifi
Recruiting Study Name: The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
Condition: Ovarian Hyperstimulation Syndrome
Date: 2015-11-24
Interventions:
  • Drug: Late Cabergoline 0.5mg C
Completed Study Name: Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
Condition: Ovarian Hyperstimulation Syndrome
Date: 2009-02-02
Next >>>